Pharma Pulse: Antengene–UCB $1.18 Billion License Agreement and AI-Driven Value Chain Efficiencies
In today’s Pharma Pulse, Antengene and UCB ink a $1.18 billion global deal for ATG-201 to target autoimmune diseases, while AI partnerships and Pharma 4.0 technologies accelerate drug development and ...
Founder, Chairman, and CEO, Robert Friedland, and Co-Founder and Chief Technology Officer, Laurent Frescaline, of I-Pulse, ...
Log-hub launches Supply Chain Analytics Pulse, a free-of-charge channel designed to empower professionals with cutting-edge knowledge and strategies. SCHINDELLEGI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results